OTCMKTS:AWKNF

Awakn Life Sciences (AWKNF) Stock Price, News & Analysis

$0.13
0.00 (0.00%)
(As of 05/2/2024 ET)
Today's Range
$0.13
$0.13
50-Day Range
$0.09
$0.16
52-Week Range
$0.04
$0.36
Volume
1,000 shs
Average Volume
19,658 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AWKNF stock logo

About Awakn Life Sciences Stock (OTCMKTS:AWKNF)

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

AWKNF Stock Price History

AWKNF Stock News Headlines

Forget Bitcoin: This $8 Stock Is the Next Big Thing
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Forget Bitcoin: This $8 Stock Is the Next Big Thing
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Joanna Goddard Loves a Smash and Grab
See More Headlines
Receive AWKNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Awakn Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:AWKNF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
44
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. George Scorsis (Age 46)
    Co-founder & Chairman of the Board
  • Mr. Anthony Tennyson
    Co-founder, President, CEO & Director
  • Mr. Jonathan James Held C.A. (Age 38)
    CPA, CA, Interim CFO, Chief Business Officer & Secretary
    Comp: $109.58k
  • Prof. David John Nutt DM
    FMedSci, FRCP, FRCPsych, FSB, Ph.D., Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer

AWKNF Stock Analysis - Frequently Asked Questions

How have AWKNF shares performed in 2024?

Awakn Life Sciences' stock was trading at $0.1012 at the start of the year. Since then, AWKNF shares have increased by 24.9% and is now trading at $0.1264.
View the best growth stocks for 2024 here
.

Are investors shorting Awakn Life Sciences?

Awakn Life Sciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,200 shares, an increase of 120.0% from the March 31st total of 1,000 shares. Based on an average trading volume of 47,400 shares, the short-interest ratio is presently 0.0 days.
View Awakn Life Sciences' Short Interest
.

How do I buy shares of Awakn Life Sciences?

Shares of AWKNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AWKNF) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners